Trial Profile
Clinical significance of Malnutrition-Inflammation-Atherosclerosis Syndrome in the patients on maintenance hemodialysis.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 10 Jan 2012
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary)
- Indications Atherosclerosis
- Focus Therapeutic Use
- 10 Jan 2012 New trial record